Baillie Gifford - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$155,794,000
+11.5%
1,377,493
-1.3%
0.21%
+3.4%
Q1 2017$139,709,000
-8.0%
1,395,284
-1.3%
0.20%
-18.8%
Q4 2016$151,931,000
-15.4%
1,413,045
-2.1%
0.25%
-11.0%
Q3 2016$179,643,000
+15.7%
1,443,152
-1.2%
0.28%
+1.4%
Q2 2016$155,307,0001,460,7520.28%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders